Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Ask a
question
Favorite
In SLE patients, disease activity was assessed by the Systemic Lupus Erythematosus Activity Index 2000 (SLEDAI-2K) and disease damage by Systemic Lupus International Collaborating Clinics/ACR Damage Index (SDI) [23, 24].
SSc patients were grouped in limited cutaneous (lcSSc) and diffuse cutaneous (dcSSc) according to LeRoy [25]. The modified Rodnan skin score (mRss) was used to evaluate the skin thickening [26]. Disease activity and disease severity were assessed by disease activity index (DAI) and disease severity scale (DSS) [27, 28].
Copyright and License information: The Author(s) ©2021
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
